Early insulin pump system for new type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an early use of an automated insulin delivery system for people recently diagnosed with type 1 diabetes. The goal is to see if starting this technology soon after diagnosis helps with blood sugar control and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have been diagnosed with type 1 diabetes within the past 2 weeks.
- You must be planning to get ongoing care at Stanford Children's Pediatric Diabetes Clinic.
- This study is for people who are new to type 1 diabetes management.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an automated insulin pump system that adjusts insulin delivery to help keep blood sugar levels stable during pregnancy. It may reduce the burden of managing type 1 diabetes and improve outcomes for you and your baby.
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
This study is testing whether an automated insulin delivery system (often called an artificial pancreas) can help adults who have just been diagnosed with type 1 diabetes manage their blood sugar levels. It aims to improve long-term control and make day-to-day management easier.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.